Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Metra, Bayer Corp. deal

MTRA and Bayer's diagnostics division will develop MTRA's biochemical bone markers internationally. Bayer will market automated central laboratory

Read the full 184 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE